BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15164008)

  • 21. A new paradigm for translational control: inhibition via 5'-3' mRNA tethering by Bicoid and the eIF4E cognate 4EHP.
    Cho PF; Poulin F; Cho-Park YA; Cho-Park IB; Chicoine JD; Lasko P; Sonenberg N
    Cell; 2005 May; 121(3):411-23. PubMed ID: 15882623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural studies of the eIF4E-VPg complex reveal a direct competition for capped RNA: Implications for translation.
    Coutinho de Oliveira L; Volpon L; Rahardjo AK; Osborne MJ; Culjkovic-Kraljacic B; Trahan C; Oeffinger M; Kwok BH; Borden KLB
    Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24056-24065. PubMed ID: 31712417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eukaryotic translation initiation is controlled by cooperativity effects within ternary complexes of 4E-BP1, eIF4E, and the mRNA 5' cap.
    Modrak-Wojcik A; Gorka M; Niedzwiecka K; Zdanowski K; Zuberek J; Niedzwiecka A; Stolarski R
    FEBS Lett; 2013 Dec; 587(24):3928-34. PubMed ID: 24211447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. eIF4E-binding proteins: new factors, new locations, new roles.
    Kamenska A; Simpson C; Standart N
    Biochem Soc Trans; 2014 Aug; 42(4):1238-45. PubMed ID: 25110031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homeodomain proteins and eukaryotic translation initiation factor 4E (eIF4E): an unexpected relationship.
    Topisirovic I; Borden KL
    Histol Histopathol; 2005 Oct; 20(4):1275-84. PubMed ID: 16136508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. eIF4E-bound mRNPs are substrates for nonsense-mediated mRNA decay in mammalian cells.
    Rufener SC; Mühlemann O
    Nat Struct Mol Biol; 2013 Jun; 20(6):710-7. PubMed ID: 23665581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
    Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
    J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Characterization of the Interaction Between the Methyl-7-Guanosine Cap Maturation Enzyme RNMT and the Cap-Binding Protein eIF4E.
    Osborne MJ; Volpon L; Memarpoor-Yazdi M; Pillay S; Thambipillai A; Czarnota S; Culjkovic-Kraljacic B; Trahan C; Oeffinger M; Cowling VH; Borden KLB
    J Mol Biol; 2022 Mar; 434(5):167451. PubMed ID: 35026230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E.
    Culjkovic B; Topisirovic I; Borden KL
    Cell Cycle; 2007 Jan; 6(1):65-9. PubMed ID: 17245113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cap-binding activity of an eIF4E homolog from Leishmania.
    Yoffe Y; Zuberek J; Lewdorowicz M; Zeira Z; Keasar C; Orr-Dahan I; Jankowska-Anyszka M; Stepinski J; Darzynkiewicz E; Shapira M
    RNA; 2004 Nov; 10(11):1764-75. PubMed ID: 15388875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for mRNA Cap-Binding regulation of eukaryotic initiation factor 4E by 4E-binding protein, studied by spectroscopic, X-ray crystal structural, and molecular dynamics simulation methods.
    Tomoo K; Matsushita Y; Fujisaki H; Abiko F; Shen X; Taniguchi T; Miyagawa H; Kitamura K; Miura K; Ishida T
    Biochim Biophys Acta; 2005 Dec; 1753(2):191-208. PubMed ID: 16271312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. eIF4E3, a new actor in mRNA metabolism and tumor suppression.
    Volpon L; Osborne MJ; Culjkovic-Kraljacic B; Borden KL
    Cell Cycle; 2013 Apr; 12(8):1159-60. PubMed ID: 23587918
    [No Abstract]   [Full Text] [Related]  

  • 33. Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment.
    Piserà A; Campo A; Campo S
    J Genet Genomics; 2018 Jan; 45(1):13-24. PubMed ID: 29396141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biophysical approach to studies of cap-eIF4E interaction by synthetic cap analogs.
    Niedzwiecka A; Stepinski J; Antosiewicz JM; Darzynkiewicz E; Stolarski R
    Methods Enzymol; 2007; 430():209-45. PubMed ID: 17913640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eIF4E, the mRNA cap-binding protein: from basic discovery to translational research.
    Sonenberg N
    Biochem Cell Biol; 2008 Apr; 86(2):178-83. PubMed ID: 18443631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target.
    Jia Y; Polunovsky V; Bitterman PB; Wagner CR
    Med Res Rev; 2012 Jul; 32(4):786-814. PubMed ID: 22495651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E.
    Schwartz DC; Parker R
    Mol Cell Biol; 2000 Nov; 20(21):7933-42. PubMed ID: 11027264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. eIF4E as a molecular wildcard in metazoans RNA metabolism.
    Hernández G; Vazquez-Pianzola P
    Biol Rev Camb Philos Soc; 2023 Dec; 98(6):2284-2306. PubMed ID: 37553111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
    Fan S; Li Y; Yue P; Khuri FR; Sun SY
    Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.